Total revenues for Q1 2026 were $3.416 billion, compared to $3.224 billion in Q1 2025. Net income attributable to DaVita Inc. was $197.5 million, or $2.87 per diluted share. U.S. dialysis patient service revenues reached $2.935 billion, up from $2.817 billion in the prior year period. Operating income for the quarter was $481.9 million, an increase from $438.9 million in Q1 2025. The company repurchased 3.0 million shares of common stock for $402.9 million during the quarter.